IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals
K. Badenhoop et al., IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals, DIABETES, 48(1), 1999, pp. 215-218
Recently, human endogenous retrovirus type It (HERV-K [IDDMK(1,2)22]) was i
solated from an IDDM patient's beta-cell supernatant and shown to be implic
ated in expression as a superantigen. Furthermore, HERV-K RNA was found in
plasma samples from newly diagnosed patients but not in those from healthy
control subjects, We had earlier identified the presence of a HERV-K long t
erminal repeat element of the HLA DQ gene (DQ-LTR) to be positively associa
ted with IDDM, which led us to investigate whether DQ-LTR is related to tra
nscription of the putative retroviral superantigen. Additionally, we sought
immunological evidence to determine whether those retroviral antigens coul
d evoke an antibody response. Patients with IDDM (n = 14), Hashimoto's thyr
oiditits (n = 5), and Graves' disease (n = 12), as well as healthy control
subjects (n = 12): were investigated, as were four nuclear families of Grav
es' disease patients and two Of IDDM patients. RNA was isolated from plasma
and peripheral blood lymphocytes and subjected to reverse transcription-po
lymerase chain reaction for transcripts of the env region of the HERV-K (ID
DMK(1,2)22) sequence, We identified ena transcripts in both plasma and peri
pheral blood lymphocytes in all individuals studied: patients with recent-o
nset or long-standing IDDM, their relatives, and healthy control subjects,
as well as patients with thyroid autoimmune disorders. Furthermore, we scre
ened the sera of patients (n = 62) and control subjects (n = 35) for eviden
ce of humoral immunity against HERV-K by Western blot specific for the ENV
protein. Similar frequencies of antibody-positives were observed both in pa
tients with IDDM (29%) and in healthy control subjects (26%), We conclude t
hat neither the ubiquitous HERV-K transcripts nor the comparable percentage
of ENV protein antibodies are associated with IDDM. An earlier, presymptom
atic antibody response against HERV-K (IDDMK(1,22)22) ENV cannot be ruled o
ut. However the superantigen hypothesis of an endogenous retrovirus in beta
-cell autoimmunity awaits confirmation.